Trial Profile
Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 02 May 2018
Price :
$35
*
At a glance
- Drugs Perflubutane (Primary)
- Indications Liver cancer
- Focus Diagnostic use
- Acronyms SCAN
- 15 May 2017 New trial record
- 18 Apr 2017 Trial design published in the BMC Cancer.